OGI — Organigram Holdings Income Statement
0.000.00%
Last trade - 00:00
- $183.43m
- $124.50m
- CA$161.64m
- 36
- 57
- 53
- 47
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 13 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 80.4 | 86.8 | 79.2 | 146 | 162 |
Cost of Revenue | |||||
Gross Profit | 37.9 | -12.1 | -24.4 | -8.43 | -31 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 75.9 | 227 | 169 | 188 | 424 |
Operating Profit | 4.54 | -141 | -89.7 | -42.7 | -263 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.88 | -147 | -131 | -14.4 | -252 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.5 | -136 | -131 | -14.3 | -249 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -9.54 | -136 | -131 | -14.3 | -249 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.54 | -136 | -131 | -14.3 | -249 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.436 | -1.96 | -1.81 | -0.434 | -1.93 |
Dividends per Share |